Chimerix reported 62.55M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Ardelyx ARDX:US $ 114.22M 19.42M
Chimerix CMRX:US 62.55M 33.25M
Curis CRIS:US $ 126.14M 3.76M
Dynavax Technologies DVAX:US $ 940.52M 32.01M
Emergent Biosolutions EBS:US $ 1100.3M 171.8M
Epizyme EPZM:US $ 228.71M 22.66M
Gilead Sciences GILD:US $ 12629M 2143M
Glaxosmithkline GSK:US $ 28988M 10314M
Life Technologies LIFE:US $ 103.12M 10.45M
Merk MRK:US $ 31184M 918M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Novavax NVAX:US $ 2347.41M 192.29M
Xoma XOMA:US $ 89.61M 7.36M